SONYA JOSEPH: Open Payments
NPI 1285242156 · ROWLETT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 37 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $249 · 2025 $747
Food & beverage: $747
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $123 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $108 |
| Lilly USA, LLC | 5 | $103 |
| Antares Pharma, Inc. | 4 | $61 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 4 | $51 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $47 |
| Corcept Therapeutics | 1 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Amgen Inc. | 2 | $28 |
Products named: JARDIANCE, Wegovy, XYOSTED, Ozempic, TRELEGY ELLIPTA, VOQUEZNA, Quviviq, Korlym.
Industry payments across TX — which companies pay providers there.
